27 Results for "

human P2X7

" in MedChemExpress (MCE) Product Catalog:
Products (27)

27 Results for "human P2X7" in MCE Product Catalog:

17
17 Publications Verification
Cat. No.: HY-50697
CAS No.: 861393-28-4
Target:  

P2X Receptor

Research Areas:  

Neurological Disease

A-740003 is a potent, selective and competitive P2X7 receptor antagonist with IC50 values are 18 and 40 nM for rat and human P2X7 receptors, respectively.
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-101418
CAS No.: 1428327-31-4
Purity:  99.79%
Target:  

P2X Receptor

Research Areas:  

Neurological Disease

JNJ-47965567 is a centrally permeable, high-affinity, selective P2X7 antagonist, with pKis of 7.9 and 8.7 for human and rat P2X7, respectively. JNJ-47965567 can be used to probe the role of central P2X7 in rodent models of CNS pathophysiology .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-100483
CAS No.: 1125758-85-1
Purity:  98.68%
Target:  

P2X Receptor

Research Areas:  

Neurological Disease Cancer

A-804598 is a BBB penetrant, competitive and selective P2X7 receptor antagonist with IC50s of 9 nM, 10 nM and 11 nM for mouse, rat and human P2X7 receptors, respectively .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-108669
CAS No.: 607378-18-7
Purity:  99.93%
Target:  

P2X Receptor

Research Areas:  

Neurological Disease Cancer

AZ10606120 dihydrochloride is a selective, high affinity antagonist for P2X7 receptor (P2X7R) at human and rat with an IC50 of about 10 nM. AZ10606120 dihydrochloride is little or no effect at other P2XR subtypes. AZ10606120 dihydrochloride has anti-depressant effects and reduces tumour growth .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-13954
CAS No.: 870061-27-1
Purity:  98.08%
A 839977 is a P2X7 selective antagonist; it blocks BzATP-evoked calcium influx at recombinant human, rat and mouse P2X7 receptors (IC50 values are 20 nM, 42 nM and 150 nM respectively) and reduces inflammatory and neuropathic pain in animal models; the antihyperalgesic effects of P2X7 receptor blockade are mediated by blocking the release of IL-1beta .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-15469
CAS No.: 1019779-04-4
Target:  

P2X Receptor

Research Areas:  

Neurological Disease

GW791343 dihydrochloride is a potent human P2X7 receptor negative allosteric modulator (exhibits species-specific activity), produces a non-competitive antagonist effect on human P2X7 receptor, with a pIC50 of 6.9-7.2. GW791343 dihydrochloride can enhance ATP rhythm. GW791343 dihydrochloride can be used in study of neurological disease .
loading...
    loading...
Cat. No.: HY-B1901
CAS No.: 56839-43-1
Synonyms: (±)-Eperisone hydrochloride
Target:  

P2X Receptor

Research Areas:  

Neurological Disease

Eperisone Hydrochloride ((±)-Eperisone hydrochloride) is an orally active antispastic agent with a vasodilator effect, used for the research of muscle stiffness and pain. Eperisone Hydrochloride is a potent and selectively P2X7 receptor antagonist, also shows antagonism for human P2X3. Eperisone Hydrochloride works by relaxing both skeletal muscles and vascularsmooth muscles, demonstrating a variety of effects such as reduction ofmyotonia, improvement of circulationand and suppression of the pain reflex .
loading...
    loading...
Cat. No.: HY-123205
CAS No.: 60607-34-3
Purity:  99.56%
Synonyms: KW-4354
Oxatomide (KW-4354) is an orally active dual antagonist of the H1-histamine receptor and the P2X7 receptor, as well as an inhibitor of serotonin. Oxatomide possesses antihistaminic, antiallergic and anti-inflammatory activities. Oxatomide can be used in the research of allergic diseases .
loading...
    loading...
Cat. No.: HY-132981
CAS No.: 2097117-06-9
Purity:  99.71%
Target:  

P2X Receptor

Research Areas:  

Neurological Disease

Lu AF27139 is a potent, selective, and orally active antagonist of P2X7 receptor (IC50s of 12 and 2.4 nM for human and rat, Kis of 22, 54, and 13 nM for mouse, human, and rat, respectively). Lu AF27139 has rodent-active and CNS-penetrant character. Lu AF27139 has the potential for the research of CNS diseases .
loading...
    loading...
Cat. No.: HY-B1901R
CAS No.: 56839-43-1
Synonyms: (±)-Eperisone hydrochloride (Standard)
Research Areas:  

Neurological Disease

Eperisone (hydrochloride) (Standard) is the analytical standard of Eperisone (hydrochloride). This product is intended for research and analytical applications. Eperisone Hydrochloride ((±)-Eperisone hydrochloride) is an orally active antispastic agent with a vasodilator effect, used for the research of muscle stiffness and pain. Eperisone Hydrochloride is a potent and selectively P2X7 receptor antagonist, also shows antagonism for human P2X3. Eperisone Hydrochloride works by relaxing both skeletal muscles and vascularsmooth muscles, demonstrating a variety of effects such as reduction ofmyotonia, improvement of circulationand and suppression of the pain reflex .
loading...
    loading...
Cat. No.: HY-19888
CAS No.: 1001389-72-5
GSK-1482160 is an orally active and blood-brain barrier penetrant P2X7 receptor (P2X7R) negative allosteric modulator with pIC50s of 8.5 (human) and 6.5 (rat). GSK-1482160 reduces the efficacy of ATP at the P2X7 receptor without affecting its affinity, thereby inhibiting the release of IL-1β. GSK-1482160 is an effective radioligand and can be labeled with radioactive isotopes like 11C or 18F to image P2X7R. GSK-1482160 can be used for the studies of chronic joint pain and chronic constriction injury (CCI) .
loading...
    loading...
Cat. No.: HY-108670
CAS No.: 227088-94-0
Purity:  99.54%
Target:  

P2X Receptor

Research Areas:  

Inflammation/Immunology

AZ11645373 is a highly selective and potent antagonist at human but not rat P2X7 receptors,AZ11645373 inhibits ATP-evoked IL-1β release from lipopolysaccharide-activated THP-1 cells , with an IC50 value of 90 nM .
loading...
    loading...
Cat. No.: HY-123481
CAS No.: 1428327-35-8
Purity:  98.15%
Target:  

P2X Receptor

Research Areas:  

Metabolic Disease

JNJ-42253432 is a CNS-penetrant, high-affinity and orally active P2X7 antagonist, with pKi values of 9.1 and 7.9 for rat and human P2X7 channels, respectively .
loading...
    loading...
Cat. No.: HY-15470
CAS No.: 309712-55-8
Target:  

P2X Receptor

Research Areas:  

Neurological Disease

GW791343 trihydrochloride is a potent human P2X7 receptor negative allosteric modulator (exhibits species-specific activity), produces a non-competitive antagonist effect on human P2X7 receptor, with a pIC50 of 6.9-7.2. GW791343 trihydrochloride can enhance ATP rhythm. GW791343 trihydrochloride can be used in study of neurological disease .
loading...
    loading...
Cat. No.: HY-179373
UB-MBX-46 is a potent and selective P2X7 receptor antagonist with IC50s of 0.514 nM (hP2X7R), 40.6 nM (rP2X7R), and 4.52 nM (mP2X7R), respectively. UB-MBX-46 interacts with the classical allosteric pocket of the human P2X7 receptor. UB-MBX-46 can be used for cancer, atherosclerosis, and neurode generation research .
loading...
    loading...
Cat. No.: HY-148558
CAS No.: 1627900-92-8
Target:  

P2X Receptor

Research Areas:  

Neurological Disease

P2X7 receptor antagonist-3 is a potent P2X7 receptor antagonist with P2X7R IC50 values of 4.2 nM in humans and 6.8 nM in rats .
loading...
    loading...
Cat. No.: HY-124300
CAS No.: 1627900-41-7
Target:  

P2X Receptor

Research Areas:  

Others

JNJ-54166060 is a potent and selective P2X7 receptor antagonist, with IC50s of 4/115/72 nM for human/rat/mouse P2X7 receptor, respectively .
loading...
    loading...
Cat. No.: HY-171462
CAS No.: 2133010-38-3
SMW139 is a selective allosteric antagonist of P2X7 receptor, with a Ki value of 32 nM for human P2X7R. The half-life of SMW139 in rat liver microsomes is 47 minutes. SMW139 can be used for inflammation, Alzheimer’s disease, multiple sclerosis study .
loading...
    loading...
Cat. No.: HY-123382
CAS No.: 1695551-19-9
Target:  

Drug Isomer

GSK-1482160 isomer is the isomer of GSK-1482160 (HY-19888). GSK-1482160 is an orally active and blood-brain barrier penetrant P2X7 receptor (P2X7R) negative allosteric modulator with pIC50s of 8.5 (human) and 6.5 (rat). GSK-1482160 reduces the efficacy of ATP at the P2X7 receptor without affecting its affinity, thereby inhibiting the release of IL-1β. GSK-1482160 is an effective radioligand and can be labeled with radioactive isotopes like 11C or 18F to image P2X7R. GSK-1482160 can be used for the studies of chronic joint pain and chronic constriction injury (CCI).
loading...
    loading...
Cat. No.: HY-101418R
CAS No.: 1428327-31-4
Research Areas:  

Neurological Disease

JNJ-47965567 (Standard) is the analytical standard of JNJ-47965567 (HY-101418). This product is intended for research and analytical applications. JNJ-47965567 is a centrally permeable, high-affinity, selective P2X7 antagonist, with pKis of 7.9 and 8.7 for human and rat P2X7, respectively. JNJ-47965567 can be used to probe the role of central P2X7 in rodent models of CNS pathophysiology .
loading...
    loading...